SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-12-001390
Filing Date
2012-06-18
Accepted
2012-06-18 16:54:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422end_06072012.htm SC 13G 184670
2 JOINT FILING AMENDMENT ex991to13g07422end_06072012.htm EX-99.1 26768
  Complete submission text file 0000921895-12-001390.txt   212961
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Subject) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86126 | Film No.: 12912919
SIC: 2834 Pharmaceutical Preparations